MAPT and Alzheimer disease: DAPK1 contributes to the pathogenesis of AD by the amyloidogenic processing of amyloid precursor protein and by phosphoryl­ating and stabilizing tau aggregates (Kim et al., 2016 ▸; Farag & Roh, 2019 ▸; Kim et al., 2014 ▸).